首页 > 最新文献

Dermatology Research and Practice最新文献

英文 中文
Intralesional Bleomycin for the Treatment of Resistant Palmoplantar and Periungual Warts. 局部注射博莱霉素治疗耐药性掌跖疣和掌周疣
IF 1.5 Q2 Medicine Pub Date : 2021-10-18 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8655004
Suchana Marahatta, Dhan Keshar Khadka, Sudha Agrawal, Arpana Rijal

Introduction: Periungual, palmar, and plantar warts are difficult to treat with poor treatment response. Intralesional (IL) bleomycin has shown promising results for their treatment in a few reports. However, we need further evidence before opting it for treating difficult sites and resistant warts. Hence, we conducted this study to assess the efficacy and safety of IL bleomycin for the treatment of resistant palmoplantar and periungual warts.

Methods: In this retrospective study, we included all patients who were given IL bleomycin for warts over a year. Maximum three sittings of bleomycin (1 mg/ml) were given monthly, and they were followed up for 3 months after the procedure. The response was categorized as complete, near-complete, significant, moderate, mild, and no clearance for 100%, 75-99%, 50-74%, 25-49%, 1-25%, and 0% clearance, respectively.

Results: Out of 29 patients, follow-up details were available only in 19 patients (53 warts). The mean duration was 2.5 ± 1.47 years. The number of past interventions ranged from 2-4. Wart clearance after the first intervention was complete in 36.84%, near-complete in 26.31%, significant in 26.31%, and moderate in 10.53%. Wart clearance after the last intervention was complete in 89.47% and near-complete in 10.52% of patients. However, during 3 months of follow-up after the last injection, 15.78% had a recurrence. None of them had severe local and systemic side effects.

Conclusions: IL bleomycin could be a better treatment option for the treatment of resistant and difficult warts. However, we observed a higher recurrence rate even in a shorter follow-up. Hence, we need further studies with larger samples.

介绍:掌周、掌跖和跖疣难以治疗,且治疗效果不佳。在一些报道中,局部注射博莱霉素(IL)对治疗这些疣有很好的效果。然而,我们需要更多的证据,才能将其用于治疗难治部位和耐药疣。因此,我们开展了这项研究,以评估IL博莱霉素治疗耐药掌跖疣和掌周疣的有效性和安全性:在这项回顾性研究中,我们纳入了所有在一年内接受过 IL 博莱霉素治疗的尖锐湿疣患者。每月最多使用三次博莱霉素(1 毫克/毫升),术后随访 3 个月。反应分为完全清除、接近完全清除、显著清除、中度清除、轻度清除和未清除,清除率分别为100%、75%-99%、50%-74%、25%-49%、1%-25%和0%:在 29 名患者中,只有 19 名患者(53 个疣体)获得了随访详情。平均病程为 2.5 ± 1.47 年。既往干预次数为 2-4 次不等。首次干预后疣体完全清除的占 36.84%,接近完全清除的占 26.31%,显著清除的占 26.31%,中度清除的占 10.53%。最后一次干预后,89.47%的患者疣体完全清除,10.52%的患者接近完全清除。然而,在最后一次注射后的 3 个月随访中,15.78% 的患者复发。结论:IL博莱霉素是一种较好的抗癌药物:IL博莱霉素可能是治疗耐药性尖锐湿疣和疑难尖锐湿疣的更好治疗方案。结论:IL博莱霉素可能是治疗耐药性尖锐湿疣和疑难性尖锐湿疣的较佳治疗方案。因此,我们需要对更大样本进行进一步研究。
{"title":"Intralesional Bleomycin for the Treatment of Resistant Palmoplantar and Periungual Warts.","authors":"Suchana Marahatta, Dhan Keshar Khadka, Sudha Agrawal, Arpana Rijal","doi":"10.1155/2021/8655004","DOIUrl":"10.1155/2021/8655004","url":null,"abstract":"<p><strong>Introduction: </strong>Periungual, palmar, and plantar warts are difficult to treat with poor treatment response. Intralesional (IL) bleomycin has shown promising results for their treatment in a few reports. However, we need further evidence before opting it for treating difficult sites and resistant warts. Hence, we conducted this study to assess the efficacy and safety of IL bleomycin for the treatment of resistant palmoplantar and periungual warts.</p><p><strong>Methods: </strong>In this retrospective study, we included all patients who were given IL bleomycin for warts over a year. Maximum three sittings of bleomycin (1 mg/ml) were given monthly, and they were followed up for 3 months after the procedure. The response was categorized as complete, near-complete, significant, moderate, mild, and no clearance for 100%, 75-99%, 50-74%, 25-49%, 1-25%, and 0% clearance, respectively.</p><p><strong>Results: </strong>Out of 29 patients, follow-up details were available only in 19 patients (53 warts). The mean duration was 2.5 ± 1.47 years. The number of past interventions ranged from 2-4. Wart clearance after the first intervention was complete in 36.84%, near-complete in 26.31%, significant in 26.31%, and moderate in 10.53%. Wart clearance after the last intervention was complete in 89.47% and near-complete in 10.52% of patients. However, during 3 months of follow-up after the last injection, 15.78% had a recurrence. None of them had severe local and systemic side effects.</p><p><strong>Conclusions: </strong>IL bleomycin could be a better treatment option for the treatment of resistant and difficult warts. However, we observed a higher recurrence rate even in a shorter follow-up. Hence, we need further studies with larger samples.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"8655004"},"PeriodicalIF":1.5,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39565636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicoepidemiology of Skin Diseases in Children Seen at the University Hospital Center Morafeno, Toamasina, Madagascar. 马达加斯加Toamasina Morafeno大学医院中心儿童皮肤病的临床流行病学研究
IF 1.5 Q2 Medicine Pub Date : 2021-09-09 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6456448
Irina Mamisoa Ranaivo, Fandresena Arilala Sendrasoa, Malalaniaina Andrianarison, Moril Sata, Onivola Raharolahy, Dimby Stephane Ralandison, Lala Soavina Ramarozatovo, Fahafahantsoa Rapelanoro Rabenja

Introduction: The child's skin diseases are common and very diverse. Many studies concerning pediatric dermatoses have been carried out in Africa and the rest of the world. Few epidemioclinical data reflect these skin diseases in children, especially in the east coast of Madagascar. We aim to describe the pattern skin diseases among children seen at the University Hospital Center Morafeno, Toamasina, Madagascar. Patients and Methods. A retrospective study over a 3-year period from January 2017 to December 2019 was conducted in children seen in the Dermatology Department of University Hospital Center Morafeno, Toamasina, with skin diseases.

Results: During the study period, 347 children out of the 1584 new patients were retained with a sex ratio of 0.86. The mean age was 6.4 years old. The main diseases identified were skin infectious diseases (43, 23%), allergic dermatoses (24.21%), and autonomous dermatosis (15.56%).

Conclusion: Our study revealed the importance of infectious and allergic dermatoses in Toamasina. It is necessary to carry out simple preventive actions such as hygiene.

儿童的皮肤病很常见,而且种类繁多。在非洲和世界其他地区开展了许多关于儿童皮肤病的研究。很少有流行病学临床数据反映这些皮肤病在儿童中,特别是在马达加斯加东海岸。我们的目的是描述在马达加斯加Toamasina Morafeno大学医院中心看到的儿童皮肤病的模式。患者和方法。2017年1月至2019年12月,对在托阿马西纳大学医院中心莫拉菲诺皮肤科就诊的皮肤病儿童进行了一项为期3年的回顾性研究。结果:在研究期间,1584例新患者中有347例儿童保留,性别比为0.86。平均年龄为6.4岁。主要疾病为皮肤感染性疾病(43.23%)、变应性皮肤病(24.21%)和自发性皮肤病(15.56%)。结论:我们的研究揭示了传染性和变应性皮肤病在Toamasina中的重要性。有必要采取简单的预防措施,如卫生。
{"title":"Clinicoepidemiology of Skin Diseases in Children Seen at the University Hospital Center Morafeno, Toamasina, Madagascar.","authors":"Irina Mamisoa Ranaivo,&nbsp;Fandresena Arilala Sendrasoa,&nbsp;Malalaniaina Andrianarison,&nbsp;Moril Sata,&nbsp;Onivola Raharolahy,&nbsp;Dimby Stephane Ralandison,&nbsp;Lala Soavina Ramarozatovo,&nbsp;Fahafahantsoa Rapelanoro Rabenja","doi":"10.1155/2021/6456448","DOIUrl":"https://doi.org/10.1155/2021/6456448","url":null,"abstract":"<p><strong>Introduction: </strong>The child's skin diseases are common and very diverse. Many studies concerning pediatric dermatoses have been carried out in Africa and the rest of the world. Few epidemioclinical data reflect these skin diseases in children, especially in the east coast of Madagascar. We aim to describe the pattern skin diseases among children seen at the University Hospital Center Morafeno, Toamasina, Madagascar. <i>Patients and Methods</i>. A retrospective study over a 3-year period from January 2017 to December 2019 was conducted in children seen in the Dermatology Department of University Hospital Center Morafeno, Toamasina, with skin diseases.</p><p><strong>Results: </strong>During the study period, 347 children out of the 1584 new patients were retained with a sex ratio of 0.86. The mean age was 6.4 years old. The main diseases identified were skin infectious diseases (43, 23%), allergic dermatoses (24.21%), and autonomous dermatosis (15.56%).</p><p><strong>Conclusion: </strong>Our study revealed the importance of infectious and allergic dermatoses in Toamasina. It is necessary to carry out simple preventive actions such as hygiene.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"6456448"},"PeriodicalIF":1.5,"publicationDate":"2021-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39430026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trichloroacetic Acid Peeling for Treating Photoaging: A Systematic Review. 三氯乙酸脱皮治疗光老化的系统综述。
IF 1.5 Q2 Medicine Pub Date : 2021-08-30 eCollection Date: 2021-01-01 DOI: 10.1155/2021/3085670
Irma Bernadette S Sitohang, Lili Legiawati, Lis Surachmiati Suseno, Fadhila Dea Safira

Photoaging can significantly contribute to lower quality of life. Medium-deep peeling using trichloroacetic acid allows controlled keratocoagulation through the dermis and into the dermal papillary layer that is effective for skin rejuvenation. The purpose of this article is to give updates regarding the efficacy, possible adverse events, and patient satisfaction of trichloroacetic acid (TCA) peeling for skin rejuvenation by assessing various photoaging parameters. A systematic review of prospective trial articles collected from PubMed, MEDLINE, EMBASE, Cochrane, and Scopus databases was conducted on November 2, 2020. Treatment efficacy was assessed based on the photoaging parameters used by each study. Adverse events and patient satisfaction as the secondary outcome were assessed based on patients-perceived improvements. Five studies included three randomized comparison studies and two prospective cohort studies. These studies show that TCA peeling significantly improve the cosmesis of photoaged facial skin. Low concentration is effective for superficial sun damage. Medium-depth peels using a higher concentration of TCA or as combination therapy are effective as skin resurfacing agents to reduce wrinkles. Some adverse effects may occur but usually resolve within weeks. Overall patients were satisfied with the treatment result. An equivalent basic skin preparation such as topical retinoic acid skin priming prior to intervention is necessary for more objective comparison. Further research studies with a larger sample size and longer follow-up period are required. This evidence suggests that TCA peeling is effective in photoaging treatment, either as monotherapy or as combination therapy with other modalities.

光老化会显著降低生活质量。使用三氯乙酸进行中深度脱皮,可以通过真皮层控制角膜凝固,进入真皮层乳头状层,对皮肤再生有效。本文的目的是通过评估各种光老化参数,对三氯乙酸(TCA)脱皮用于皮肤年轻化的疗效、可能的不良事件和患者满意度进行更新。2020年11月2日,对PubMed、MEDLINE、EMBASE、Cochrane和Scopus数据库中收集的前瞻性试验文章进行了系统评价。根据每项研究使用的光老化参数评估治疗效果。不良事件和患者满意度作为次要结果根据患者感知的改善进行评估。5项研究包括3项随机比较研究和2项前瞻性队列研究。这些研究表明,TCA脱皮能显著改善光老化面部皮肤的外观。低浓度对表面晒伤有效。中等深度的去皮使用高浓度的TCA或作为联合疗法是有效的皮肤表面活性剂,以减少皱纹。可能会出现一些不良反应,但通常会在几周内消退。患者对治疗效果总体满意。为了进行更客观的比较,有必要在干预前进行等效的基础皮肤准备,如局部维甲酸皮肤启动。进一步的研究需要更大的样本量和更长的随访期。这一证据表明TCA脱皮在光老化治疗中是有效的,无论是单独治疗还是与其他方式联合治疗。
{"title":"Trichloroacetic Acid Peeling for Treating Photoaging: A Systematic Review.","authors":"Irma Bernadette S Sitohang,&nbsp;Lili Legiawati,&nbsp;Lis Surachmiati Suseno,&nbsp;Fadhila Dea Safira","doi":"10.1155/2021/3085670","DOIUrl":"https://doi.org/10.1155/2021/3085670","url":null,"abstract":"<p><p>Photoaging can significantly contribute to lower quality of life. Medium-deep peeling using trichloroacetic acid allows controlled keratocoagulation through the dermis and into the dermal papillary layer that is effective for skin rejuvenation. The purpose of this article is to give updates regarding the efficacy, possible adverse events, and patient satisfaction of trichloroacetic acid (TCA) peeling for skin rejuvenation by assessing various photoaging parameters. A systematic review of prospective trial articles collected from PubMed, MEDLINE, EMBASE, Cochrane, and Scopus databases was conducted on November 2, 2020. Treatment efficacy was assessed based on the photoaging parameters used by each study. Adverse events and patient satisfaction as the secondary outcome were assessed based on patients-perceived improvements. Five studies included three randomized comparison studies and two prospective cohort studies. These studies show that TCA peeling significantly improve the cosmesis of photoaged facial skin. Low concentration is effective for superficial sun damage. Medium-depth peels using a higher concentration of TCA or as combination therapy are effective as skin resurfacing agents to reduce wrinkles. Some adverse effects may occur but usually resolve within weeks. Overall patients were satisfied with the treatment result. An equivalent basic skin preparation such as topical retinoic acid skin priming prior to intervention is necessary for more objective comparison. Further research studies with a larger sample size and longer follow-up period are required. This evidence suggests that TCA peeling is effective in photoaging treatment, either as monotherapy or as combination therapy with other modalities.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"3085670"},"PeriodicalIF":1.5,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39421067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Knowledge, Attitude, and Practice (KAP) Survey toward Skin Cancer among Ecuadorian Population. 厄瓜多尔人皮肤癌的知识、态度和行为(KAP)调查
IF 1.5 Q3 DERMATOLOGY Pub Date : 2021-08-04 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5539149
Victor H Pinos-León, César Sandoval, Franklin Cabrera, Esmeraldas Terán, Ana Garnica, Ana Kellendonk, Mery Alvear, Carla Rosero, Lorena Vaca, Jorge Bonifaz, Anita Buestán, Claudia Armas, Raquel Trujillo, Patricio Freire, Tamara León, Giselle Erazo, Liliana García, Marcela Alzate, Vicente Toapanta, Myriam Ortega, Daniela Caicedo, Alicia Pereira, Lenin Gómez-Barreno, Juan S Izquierdo-Condoy, Merry Charlie, Esteban Ortiz-Prado, Katherine Simbaña-Rivera

Background: Skin cancer is one of the most common cancers, and melanoma is a highly preventable cancer. In Ecuador, few studies have evaluated the awareness levels of the population about the disease. For this reason, the objective of this study was to measure the level of knowledge, attitudes, and practices regarding skin cancer and its determining factors.

Methods: A cross-sectional analysis using an online self-assessment questionnaire containing 40 questions was delivered. A total of 537 participants were included in this study. Knowledge, attitude, and practice scores were assigned to each participant based on the number of correct or appropriate responses. Logistic regression analysis was used to calculate crude and adjusted odds ratios.

Results: In total, 75% of participants referenced knowledge of the harmful effects related to noncontrolled solar exposure. Concerning sunscreen, 76.7% knew the reason for using it. The female group was 1.68 times more likely to get a higher score than the male group, and the groups between 61-70 and 71-80 years were 0.30 and 0.17 times less likely to get a higher score compared with the less than 20-years-old group, respectively.

Conclusions: The findings of this study indicate the requirement to increase the population's knowledge about skin cancer and possible protection measures. For this reason, the prevention and health promotion programs at a national level from primary healthcare centers are recommended. Due to the limitation of the representativeness of the sample, the use of more studies among Ecuadorian residents of the low socioeconomic level and replication in different provinces of Ecuador is justified.

背景:皮肤癌是最常见的癌症之一,黑色素瘤是一种高度可预防的癌症。在厄瓜多尔,很少有研究评估人口对该疾病的认识水平。因此,本研究的目的是测量关于皮肤癌及其决定因素的知识、态度和实践水平。方法:采用包含40个问题的在线自评问卷进行横断面分析。本研究共纳入537名参与者。知识,态度和练习分数是根据正确或适当的回答的数量分配给每个参与者的。采用Logistic回归分析计算粗比值比和校正比值比。结果:总的来说,75%的参与者提到了与不受控制的阳光照射有关的有害影响的知识。对于防晒霜,76.7%的人知道使用防晒霜的原因。女性组获得高分的可能性是男性组的1.68倍,61-70岁组和71-80岁组获得高分的可能性分别是20岁以下组的0.30倍和0.17倍。结论:本研究结果表明,需要增加人们对皮肤癌的认识和可能的保护措施。因此,建议在国家一级的初级保健中心开展预防和健康促进计划。由于样本代表性的限制,在厄瓜多尔低社会经济水平的居民中使用更多的研究并在厄瓜多尔不同省份复制是合理的。
{"title":"Knowledge, Attitude, and Practice (KAP) Survey toward Skin Cancer among Ecuadorian Population.","authors":"Victor H Pinos-León,&nbsp;César Sandoval,&nbsp;Franklin Cabrera,&nbsp;Esmeraldas Terán,&nbsp;Ana Garnica,&nbsp;Ana Kellendonk,&nbsp;Mery Alvear,&nbsp;Carla Rosero,&nbsp;Lorena Vaca,&nbsp;Jorge Bonifaz,&nbsp;Anita Buestán,&nbsp;Claudia Armas,&nbsp;Raquel Trujillo,&nbsp;Patricio Freire,&nbsp;Tamara León,&nbsp;Giselle Erazo,&nbsp;Liliana García,&nbsp;Marcela Alzate,&nbsp;Vicente Toapanta,&nbsp;Myriam Ortega,&nbsp;Daniela Caicedo,&nbsp;Alicia Pereira,&nbsp;Lenin Gómez-Barreno,&nbsp;Juan S Izquierdo-Condoy,&nbsp;Merry Charlie,&nbsp;Esteban Ortiz-Prado,&nbsp;Katherine Simbaña-Rivera","doi":"10.1155/2021/5539149","DOIUrl":"https://doi.org/10.1155/2021/5539149","url":null,"abstract":"<p><strong>Background: </strong>Skin cancer is one of the most common cancers, and melanoma is a highly preventable cancer. In Ecuador, few studies have evaluated the awareness levels of the population about the disease. For this reason, the objective of this study was to measure the level of knowledge, attitudes, and practices regarding skin cancer and its determining factors.</p><p><strong>Methods: </strong>A cross-sectional analysis using an online self-assessment questionnaire containing 40 questions was delivered. A total of 537 participants were included in this study. Knowledge, attitude, and practice scores were assigned to each participant based on the number of correct or appropriate responses. Logistic regression analysis was used to calculate crude and adjusted odds ratios.</p><p><strong>Results: </strong>In total, 75% of participants referenced knowledge of the harmful effects related to noncontrolled solar exposure. Concerning sunscreen, 76.7% knew the reason for using it. The female group was 1.68 times more likely to get a higher score than the male group, and the groups between 61-70 and 71-80 years were 0.30 and 0.17 times less likely to get a higher score compared with the less than 20-years-old group, respectively.</p><p><strong>Conclusions: </strong>The findings of this study indicate the requirement to increase the population's knowledge about skin cancer and possible protection measures. For this reason, the prevention and health promotion programs at a national level from primary healthcare centers are recommended. Due to the limitation of the representativeness of the sample, the use of more studies among Ecuadorian residents of the low socioeconomic level and replication in different provinces of Ecuador is justified.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"5539149"},"PeriodicalIF":1.5,"publicationDate":"2021-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39312962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Contributing Factors and Outcome after Cryotherapy of Molluscum Contagiosum among Patients Attending Tertiary Hospital, Northern Tanzania: A Descriptive Prospective Cohort Study. 坦桑尼亚北部三级医院传染性软疣患者冷冻治疗后的影响因素和结果:一项描述性前瞻性队列研究。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2021-07-01 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9653651
Peter J Chapa, Daudi R Mavura, Rune Philemon, Lulyritha Kini, Elisante J Masenga

Background: Molluscum contagiosum (MC) is a benign infection caused by a member of the Poxviridae family, molluscum contagiosum virus (MCV). The contributing factors for MCV infection are different in different populations and study areas. Few studies have been conducted to determine the effectiveness of cryotherapy in the treatment of MC. The study's objectives were to determine contributing factors and outcome after cryotherapy of MC among patients attending a tertiary hospital in Northern Tanzania.

Methods: A hospital-based cohort study was conducted at the Regional Dermatology Training Centre (RDTC) from September 2018 to August 2019, involving all patients clinically diagnosed with MC. We used a consecutive sampling method to recruit study participants. We treated all participants with cryotherapy and assessed them after two weeks. Data were collected using a structured questionnaire and analyzed using Statistical Package for the Social Sciences (SPSS) software version 21.

Results: There were 49 patients with MC who agreed to participate in this study with a median age of 8 (IQR 3-22). We found 18.4% of patients with active atopic dermatitis (AD) had MC while those with a history of atopic diseases (Ad) were 32%, and 22.4% had a history of using immunosuppressive drugs. The clearance rate of cryotherapy on MC lesions was found to be 94%. Hypopigmentation was the commonest adverse effect.

Conclusion: The findings of this study show that AD and immunosuppression may be contributing to MC development. Based on the clearance rate results, cryotherapy has shown to be effective and may be used in the treatment of MC.

背景:传染性软疣(MC)是由痘病毒科成员——传染性软疣病毒(MCV)引起的一种良性感染。在不同的人群和研究区域,MCV感染的影响因素是不同的。很少有研究确定冷冻疗法治疗MC的有效性。该研究的目的是确定在坦桑尼亚北部一家三级医院接受冷冻治疗的MC患者的影响因素和结果。方法:2018年9月至2019年8月,在区域皮肤病学培训中心(RDTC)进行了一项基于医院的队列研究,纳入了所有临床诊断为MC的患者。我们采用连续抽样方法招募研究参与者。我们对所有参与者进行冷冻治疗,并在两周后对他们进行评估。使用结构化问卷收集数据,并使用社会科学统计软件包(SPSS)软件版本21进行分析。结果:49例MC患者同意参加本研究,中位年龄为8岁(IQR 3-22)。我们发现,活动性特应性皮炎(AD)患者中有18.4%患有MC,有特应性疾病(AD)病史的患者中有32%患有MC,有免疫抑制药物使用史的患者中有22.4%患有MC。冷冻治疗对MC病变的清除率为94%。色素沉着是最常见的不良反应。结论:本研究结果提示AD和免疫抑制可能参与了MC的发展。根据清除率的结果,冷冻疗法已被证明是有效的,可以用于治疗多发性硬化症。
{"title":"Contributing Factors and Outcome after Cryotherapy of Molluscum Contagiosum among Patients Attending Tertiary Hospital, Northern Tanzania: A Descriptive Prospective Cohort Study.","authors":"Peter J Chapa,&nbsp;Daudi R Mavura,&nbsp;Rune Philemon,&nbsp;Lulyritha Kini,&nbsp;Elisante J Masenga","doi":"10.1155/2021/9653651","DOIUrl":"https://doi.org/10.1155/2021/9653651","url":null,"abstract":"<p><strong>Background: </strong>Molluscum contagiosum (MC) is a benign infection caused by a member of the Poxviridae family, molluscum contagiosum virus (MCV). The contributing factors for MCV infection are different in different populations and study areas. Few studies have been conducted to determine the effectiveness of cryotherapy in the treatment of MC. The study's objectives were to determine contributing factors and outcome after cryotherapy of MC among patients attending a tertiary hospital in Northern Tanzania.</p><p><strong>Methods: </strong>A hospital-based cohort study was conducted at the Regional Dermatology Training Centre (RDTC) from September 2018 to August 2019, involving all patients clinically diagnosed with MC. We used a consecutive sampling method to recruit study participants. We treated all participants with cryotherapy and assessed them after two weeks. Data were collected using a structured questionnaire and analyzed using Statistical Package for the Social Sciences (SPSS) software version 21.</p><p><strong>Results: </strong>There were 49 patients with MC who agreed to participate in this study with a median age of 8 (IQR 3-22). We found 18.4% of patients with active atopic dermatitis (AD) had MC while those with a history of atopic diseases (Ad) were 32%, and 22.4% had a history of using immunosuppressive drugs. The clearance rate of cryotherapy on MC lesions was found to be 94%. Hypopigmentation was the commonest adverse effect.</p><p><strong>Conclusion: </strong>The findings of this study show that AD and immunosuppression may be contributing to MC development. Based on the clearance rate results, cryotherapy has shown to be effective and may be used in the treatment of MC.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"9653651"},"PeriodicalIF":1.5,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39223969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anti-Inflammatory and Restorative Effects of Olives in Topical Application. 局部使用橄榄的消炎和修复作用
IF 1.5 Q3 DERMATOLOGY Pub Date : 2021-06-26 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9927976
Mahdiyeh Taheri, Leila Amiri-Farahani

Methods: A literature search was conducted (1990-2021) in Medline, Embase, CINAHL, Google Scholar, Science Direct, SID, IranDoc, and Magiran databases. From the 102 reviewed articles, 17 articles were selected to be included in the current article.

Results: Various forms of olive have long been used to accelerate the healing of various wounds and skin damage such as diabetic foot ulcers, atopic dermatitis, diaper dermatitis, episiotomy wound, and nipple ulcer but there are still no credible documents or articles that provide reliable evidence of topical use.

Conclusion: According to the information obtained from the articles reviewed, olive oil appears to be an effective, safe, and available treatment. This study suggests that olive oil is an alternative remedy to minimize the frequent use of chemical-based treatments. More research may be beneficial to reach certainty in terms of curative properties of olive oil in similar or different injuries in different populations.

研究方法在 Medline、Embase、CINAHL、Google Scholar、Science Direct、SID、IranDoc 和 Magiran 等数据库中进行了文献检索(1990-2021 年)。结果:长期以来,人们一直使用各种形式的橄榄来加速各种伤口和皮肤损伤的愈合,如糖尿病足溃疡、特应性皮炎、尿布皮炎、外阴切开术伤口和乳头溃疡等,但目前仍没有可信的文献或文章提供外用橄榄的可靠证据:根据所查阅文章中获得的信息,橄榄油似乎是一种有效、安全且可用的治疗方法。这项研究表明,橄榄油是一种替代疗法,可以减少化学疗法的频繁使用。更多的研究可能有助于确定橄榄油对不同人群类似或不同损伤的治疗效果。
{"title":"Anti-Inflammatory and Restorative Effects of Olives in Topical Application.","authors":"Mahdiyeh Taheri, Leila Amiri-Farahani","doi":"10.1155/2021/9927976","DOIUrl":"10.1155/2021/9927976","url":null,"abstract":"<p><strong>Methods: </strong>A literature search was conducted (1990-2021) in Medline, Embase, CINAHL, Google Scholar, Science Direct, SID, IranDoc, and Magiran databases. From the 102 reviewed articles, 17 articles were selected to be included in the current article.</p><p><strong>Results: </strong>Various forms of olive have long been used to accelerate the healing of various wounds and skin damage such as diabetic foot ulcers, atopic dermatitis, diaper dermatitis, episiotomy wound, and nipple ulcer but there are still no credible documents or articles that provide reliable evidence of topical use.</p><p><strong>Conclusion: </strong>According to the information obtained from the articles reviewed, olive oil appears to be an effective, safe, and available treatment. This study suggests that olive oil is an alternative remedy to minimize the frequent use of chemical-based treatments. More research may be beneficial to reach certainty in terms of curative properties of olive oil in similar or different injuries in different populations.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"9927976"},"PeriodicalIF":1.5,"publicationDate":"2021-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39180694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. 阿布替尼治疗中重度特应性皮炎的有效性和安全性:随机临床试验的系统评价和荟萃分析
IF 1.9 Q3 DERMATOLOGY Pub Date : 2021-06-23 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8382761
Hammad Ali Fadlalmola, Muayad Saud Albadrani, Amal Mohamed Elhusein, Wahieba E Mohamedsalih, D S Veerabhadra Swamy, Daniel Mon Mamanao

Background: Atopic dermatitis (AD) is a complex, chronic, inflammatory skin disease characterized by pruritic, intense itching, and eczematous lesions affecting about 25% of children and 2% to 3% of adults worldwide. Abrocitinib is a selective inhibitor of Janus kinase-1 (JAK1) enzyme inhibiting the inflammatory process. Therefore, we aimed to assess the efficacy and safety of abrocitinib for moderate-to-severe AD.

Methods: We systematically searched PubMed, Cochrane, Web of Science, Scopus, and EczemATrials till Feb 1, 2021, for reliable trials. The analysis was conducted using an inverse-variance method. The results were pooled as mean difference/event rate and 95% confidence interval.

Results: Abrocitinib 100 mg and 200 mg were associated with higher IGA response, EASI-50% responders, EASI-75% responders, EASI-90% responders, number of participants with at least 4-point improvements in NRS, and quality of life measured by DLQI and CDLQI than placebo. Also, 100 mg and 200 mg were associated with lower SCORAD index, %BSA, PSAAD index, and POEM index than placebo. Abrocitinib 100 mg and 200 mg were not associated with adverse events such as upper respiratory tract infection, nasopharyngitis, dermatitis, atopic, any serious adverse events, and death.

Conclusion: Abrocitinib in dose 100 mg or 200 mg is an effective, well-tolerated, and promising drug in treating patients with moderate-to-severe atopic dermatitis. However, the analysis favored the efficacy of abrocitinib 200 mg over 100 mg, but side effects such as nausea and headache are likely to occur more with 200 mg.

背景:特应性皮炎(AD)是一种复杂的慢性炎症性皮肤病,以瘙痒、强烈瘙痒和湿疹病变为特征,影响全球约25%的儿童和2%至3%的成人。Abrocitinib是JAK1 (Janus kinase-1)酶的选择性抑制剂,可抑制炎症过程。因此,我们旨在评估abrocitinib治疗中重度AD的有效性和安全性。方法:我们系统地检索PubMed, Cochrane, Web of Science, Scopus和EczemATrials,直到2021年2月1日,以获得可靠的试验。采用反方差法进行分析。结果汇总为平均差异/事件率和95%置信区间。结果:与安慰剂相比,Abrocitinib 100mg和200mg与更高的IGA应答、EASI-50%应答、EASI-75%应答、EASI-90%应答、NRS改善至少4点的参与者人数以及DLQI和CDLQI测量的生活质量相关。此外,与安慰剂相比,100mg和200mg与较低的SCORAD指数、%BSA、PSAAD指数和POEM指数相关。Abrocitinib 100mg和200mg与上呼吸道感染、鼻咽炎、皮炎、特应性、任何严重不良事件和死亡等不良事件无关。结论:阿布替尼100mg或200mg是一种治疗中重度特应性皮炎的有效、耐受性良好、有前景的药物。然而,与100毫克的阿布替尼相比,200毫克的阿布替尼更有效,但200毫克的阿布替尼更可能出现恶心和头痛等副作用。
{"title":"Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.","authors":"Hammad Ali Fadlalmola, Muayad Saud Albadrani, Amal Mohamed Elhusein, Wahieba E Mohamedsalih, D S Veerabhadra Swamy, Daniel Mon Mamanao","doi":"10.1155/2021/8382761","DOIUrl":"10.1155/2021/8382761","url":null,"abstract":"<p><strong>Background: </strong>Atopic dermatitis (AD) is a complex, chronic, inflammatory skin disease characterized by pruritic, intense itching, and eczematous lesions affecting about 25% of children and 2% to 3% of adults worldwide. Abrocitinib is a selective inhibitor of Janus kinase-1 (JAK1) enzyme inhibiting the inflammatory process. Therefore, we aimed to assess the efficacy and safety of abrocitinib for moderate-to-severe AD.</p><p><strong>Methods: </strong>We systematically searched PubMed, Cochrane, Web of Science, Scopus, and EczemATrials till Feb 1, 2021, for reliable trials. The analysis was conducted using an inverse-variance method. The results were pooled as mean difference/event rate and 95% confidence interval.</p><p><strong>Results: </strong>Abrocitinib 100 mg and 200 mg were associated with higher IGA response, EASI-50% responders, EASI-75% responders, EASI-90% responders, number of participants with at least 4-point improvements in NRS, and quality of life measured by DLQI and CDLQI than placebo. Also, 100 mg and 200 mg were associated with lower SCORAD index, %BSA, PSAAD index, and POEM index than placebo. Abrocitinib 100 mg and 200 mg were not associated with adverse events such as upper respiratory tract infection, nasopharyngitis, dermatitis, atopic, any serious adverse events, and death.</p><p><strong>Conclusion: </strong>Abrocitinib in dose 100 mg or 200 mg is an effective, well-tolerated, and promising drug in treating patients with moderate-to-severe atopic dermatitis. However, the analysis favored the efficacy of abrocitinib 200 mg over 100 mg, but side effects such as nausea and headache are likely to occur more with 200 mg.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"8382761"},"PeriodicalIF":1.9,"publicationDate":"2021-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39180693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer. 非黑色素瘤皮肤癌患者血清IL-17A水平的研究
IF 1.5 Q2 Medicine Pub Date : 2021-06-18 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5540163
Mehdi Ghahartars, Fatemeh Sedaghat, Elham Khajavi, Amir Ali Nejat, Mahyar Malekzadeh, Abbas Ghaderi, Mohammad Javad Fattahi

Background: Role of interleukin 17A (IL-17A) in carcinogenesis and cancer growth is controversial. Although some researches support its antitumor activity, some others suggest that it promotes the growth and development of different types of cancer including skin cancer by activation of STAT3. Although the function of the cytokines such as IL-17A has been extensively studied in various types of cancer, nonmelanoma skin cancer (NMSC) has not received much attention. Therefore, the present study was aimed to investigate the serum levels of IL-17A in NMSC patients.

Methods: This cross-sectional study was performed on 60 patients with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) as well as 57 age-sex matched healthy individuals as control group. Measurement of IL-17A serum levels in both case and control groups was performed by a commercially reliable sandwich enzyme-linked immunosorbent assay (ELISA) kit.

Results: In this study, we observed that IL-17A serum levels in NMSC patients were significantly higher than the control group (P < 0.001). Also, both BCC and SCC patients had higher levels of IL-17A in their sera in comparison to the controls (P=0.001 and P < 0.001, respectively). However, there was no significant difference between SCC and BCC patients regarding serum levels of IL-17A.

Conclusion: According to our results, it can be concluded that IL-17A may play a role in inducing the growth and progression of NMSC and it can be used as a therapeutic target in these patients in future.

背景:白细胞介素17A (IL-17A)在肿瘤发生和肿瘤生长中的作用尚存争议。虽然一些研究支持其抗肿瘤活性,但也有一些研究认为它通过激活STAT3促进包括皮肤癌在内的不同类型癌症的生长和发展。尽管IL-17A等细胞因子在各种类型癌症中的作用已被广泛研究,但非黑色素瘤皮肤癌(non - melanoma skin cancer, NMSC)并未受到太多关注。因此,本研究旨在探讨NMSC患者血清IL-17A水平。方法:对60例基底细胞癌(BCC)和鳞状细胞癌(SCC)患者和57例年龄性别匹配的健康人作为对照组进行横断面研究。用商业上可靠的三明治酶联免疫吸附测定(ELISA)试剂盒检测病例组和对照组的血清IL-17A水平。结果:本研究中,我们观察到NMSC患者血清IL-17A水平显著高于对照组(P < 0.001)。此外,与对照组相比,BCC和SCC患者血清中IL-17A水平均较高(P分别=0.001和P < 0.001)。然而,在血清IL-17A水平方面,SCC和BCC患者之间没有显著差异。结论:根据我们的研究结果,IL-17A可能在诱导NMSC生长和进展中发挥作用,并可作为未来NMSC患者的治疗靶点。
{"title":"Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer.","authors":"Mehdi Ghahartars,&nbsp;Fatemeh Sedaghat,&nbsp;Elham Khajavi,&nbsp;Amir Ali Nejat,&nbsp;Mahyar Malekzadeh,&nbsp;Abbas Ghaderi,&nbsp;Mohammad Javad Fattahi","doi":"10.1155/2021/5540163","DOIUrl":"https://doi.org/10.1155/2021/5540163","url":null,"abstract":"<p><strong>Background: </strong>Role of interleukin 17A (IL-17A) in carcinogenesis and cancer growth is controversial. Although some researches support its antitumor activity, some others suggest that it promotes the growth and development of different types of cancer including skin cancer by activation of STAT3. Although the function of the cytokines such as IL-17A has been extensively studied in various types of cancer, nonmelanoma skin cancer (NMSC) has not received much attention. Therefore, the present study was aimed to investigate the serum levels of IL-17A in NMSC patients.</p><p><strong>Methods: </strong>This cross-sectional study was performed on 60 patients with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) as well as 57 age-sex matched healthy individuals as control group. Measurement of IL-17A serum levels in both case and control groups was performed by a commercially reliable sandwich enzyme-linked immunosorbent assay (ELISA) kit.</p><p><strong>Results: </strong>In this study, we observed that IL-17A serum levels in NMSC patients were significantly higher than the control group (<i>P</i> < 0.001). Also, both BCC and SCC patients had higher levels of IL-17A in their sera in comparison to the controls (<i>P</i>=0.001 and <i>P</i> < 0.001, respectively). However, there was no significant difference between SCC and BCC patients regarding serum levels of IL-17A.</p><p><strong>Conclusion: </strong>According to our results, it can be concluded that IL-17A may play a role in inducing the growth and progression of NMSC and it can be used as a therapeutic target in these patients in future.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"5540163"},"PeriodicalIF":1.5,"publicationDate":"2021-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39166201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Skin Diseases in a Pediatric Hospital of Nepal. 尼泊尔儿科医院的皮肤病。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2021-06-12 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6619936
Roushan Jahan, Shreedhar Khanal, Shraddha Shrestha, Niraj Parajuli

The skin diseases of pediatric population are varied which change according to age and season. There is a rarity of studies on pediatric skin conditions from Nepal. This observational study from the only tertiary care referral pediatric center of the country highlighted the burden of pediatric skin diseases in Nepalese population. All new cases of pediatric patients less than 14 years of age consulting the pediatric dermatological OPD of Kanti Children's Hospital from January 2017 to December 2017 were included in this study. Demographic details of all the patients such as age and sex were recorded. The diagnosis was made clinically in most instances and appropriate laboratory and histopathological examination were performed wherever necessary. A total of 7683 pediatric patients were included in the study. Among these, there were 4574 (59.53%) males and 3109 (40.47%) females. The most common skin condition was infections among 2463 (32.12%) followed by eczematous conditions in 1711(22.27%) and hypersensitivity reactions in 1510 (19.65%). Infections were more common during the summer months. Overall, both infectious and noninfectious skin diseases were significantly more common during the warmer (summer and spring) months as compared to colder (autumn and winter) months (p < 0.001). This study shows that the pediatric dermatoses are common in Nepalese population.

儿科人群的皮肤病是多种多样的,根据年龄和季节而变化。关于尼泊尔儿童皮肤状况的研究很少。这项来自该国唯一的三级保健转诊儿科中心的观察性研究强调了尼泊尔人口中儿科皮肤病的负担。2017年1月至2017年12月在Kanti儿童医院儿科皮肤科门诊就诊的所有14岁以下儿科新病例纳入本研究。记录所有患者的年龄、性别等人口统计信息。在大多数情况下,诊断是临床作出的,必要时进行适当的实验室和组织病理学检查。共有7683名儿科患者被纳入研究。其中,男性4574人(59.53%),女性3109人(40.47%)。2463例(32.12%)以感染为主,其次为湿疹(22.27%)和过敏反应(19.65%)。感染在夏季更为常见。总体而言,感染性和非感染性皮肤病在温暖的月份(夏季和春季)比寒冷的月份(秋季和冬季)更常见(p < 0.001)。本研究显示小儿皮肤病在尼泊尔人群中较为常见。
{"title":"Skin Diseases in a Pediatric Hospital of Nepal.","authors":"Roushan Jahan,&nbsp;Shreedhar Khanal,&nbsp;Shraddha Shrestha,&nbsp;Niraj Parajuli","doi":"10.1155/2021/6619936","DOIUrl":"https://doi.org/10.1155/2021/6619936","url":null,"abstract":"<p><p>The skin diseases of pediatric population are varied which change according to age and season. There is a rarity of studies on pediatric skin conditions from Nepal. This observational study from the only tertiary care referral pediatric center of the country highlighted the burden of pediatric skin diseases in Nepalese population. All new cases of pediatric patients less than 14 years of age consulting the pediatric dermatological OPD of Kanti Children's Hospital from January 2017 to December 2017 were included in this study. Demographic details of all the patients such as age and sex were recorded. The diagnosis was made clinically in most instances and appropriate laboratory and histopathological examination were performed wherever necessary. A total of 7683 pediatric patients were included in the study. Among these, there were 4574 (59.53%) males and 3109 (40.47%) females. The most common skin condition was infections among 2463 (32.12%) followed by eczematous conditions in 1711(22.27%) and hypersensitivity reactions in 1510 (19.65%). Infections were more common during the summer months. Overall, both infectious and noninfectious skin diseases were significantly more common during the warmer (summer and spring) months as compared to colder (autumn and winter) months (<i>p</i> < 0.001). This study shows that the pediatric dermatoses are common in Nepalese population.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"6619936"},"PeriodicalIF":1.5,"publicationDate":"2021-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39162923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Diagnosis has a High Negative Predictive Value in Evaluation of Malignant Skin Lesions. 临床诊断对恶性皮损的评价具有较高的阴性预测值。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2021-04-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6618990
Maral Seyed Ahadi, Alireza Firooz, Hoda Rahimi, Mehrdad Jafari, Zohreh Tehranchinia

Background: The increasing incidence of skin cancers in fair-skinned population and its relatively good response to treatment make its accurate diagnosis of great importance. We evaluated the accuracy of clinical diagnosis of malignant skin lesions by comparing the clinical diagnosis with histological diagnosis as the gold standard.

Materials and methods: In this retrospective study, we assessed all the pathology reports from specimens sent to a university hospital laboratory in 3 consecutive years from March 2008 to March 2010. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios were calculated for clinical diagnosis of malignant skin lesions stratified by their histological subtype.

Results: A total 4,123 specimen were evaluated. The sensitivity and specificity for clinical diagnosis of malignancy were 90.48% and 82.85%, respectively, whereas the negative predictive value was shown to be 99.06%. The positive and negative likelihood ratios were 5.23 and 0.11, respectively.

Conclusion: Pathological assessment of skin lesions remains the cornerstone of skin cancer diagnosis. The high NPV and the relatively low PPV indicate that clinical diagnosis is more efficient in ruling out malignancies rather than diagnosing them.

背景:随着皮肤白皙人群皮肤癌发病率的增加以及对治疗的较好反应,其准确诊断具有重要意义。我们将临床诊断与组织学诊断作为金标准进行比较,以评估临床诊断对皮肤恶性病变的准确性。材料与方法:回顾性分析2008年3月至2010年3月连续3年送至某大学医院化验室的所有标本病理报告。计算皮肤恶性病变按组织学亚型分层的临床诊断敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)及阳性、阴性似然比。结果:共检查标本4123例。临床诊断恶性肿瘤的敏感性和特异性分别为90.48%和82.85%,阴性预测值为99.06%。正似然比为5.23,负似然比为0.11。结论:皮肤病变的病理评估是皮肤癌诊断的基础。较高的净现值和相对较低的PPV表明临床诊断对恶性肿瘤的排除比诊断更有效。
{"title":"Clinical Diagnosis has a High Negative Predictive Value in Evaluation of Malignant Skin Lesions.","authors":"Maral Seyed Ahadi,&nbsp;Alireza Firooz,&nbsp;Hoda Rahimi,&nbsp;Mehrdad Jafari,&nbsp;Zohreh Tehranchinia","doi":"10.1155/2021/6618990","DOIUrl":"https://doi.org/10.1155/2021/6618990","url":null,"abstract":"<p><strong>Background: </strong>The increasing incidence of skin cancers in fair-skinned population and its relatively good response to treatment make its accurate diagnosis of great importance. We evaluated the accuracy of clinical diagnosis of malignant skin lesions by comparing the clinical diagnosis with histological diagnosis as the gold standard.</p><p><strong>Materials and methods: </strong>In this retrospective study, we assessed all the pathology reports from specimens sent to a university hospital laboratory in 3 consecutive years from March 2008 to March 2010. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios were calculated for clinical diagnosis of malignant skin lesions stratified by their histological subtype.</p><p><strong>Results: </strong>A total 4,123 specimen were evaluated. The sensitivity and specificity for clinical diagnosis of malignancy were 90.48% and 82.85%, respectively, whereas the negative predictive value was shown to be 99.06%. The positive and negative likelihood ratios were 5.23 and 0.11, respectively.</p><p><strong>Conclusion: </strong>Pathological assessment of skin lesions remains the cornerstone of skin cancer diagnosis. The high NPV and the relatively low PPV indicate that clinical diagnosis is more efficient in ruling out malignancies rather than diagnosing them.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2021 ","pages":"6618990"},"PeriodicalIF":1.5,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38986979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dermatology Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1